| Q43626729 | Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy |
| Q36798075 | Characterization of a potent varicella-zoster virus-encoded trans-repressor |
| Q36073807 | Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene |
| Q36698476 | Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein |
| Q36690571 | Characterization of the regulatory functions of the equine herpesvirus 1 immediate-early gene product |
| Q36650469 | Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. |
| Q28315797 | Clinical and Molecular Pathogenesis of Varicella Virus Infection |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q41177944 | Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins |
| Q45722653 | Interaction between the varicella zoster virus IE62 major transactivator and cellular transcription factor Sp1. |
| Q41332614 | Lessons to be learned from varicella-zoster virus |
| Q40224871 | Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein |
| Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
| Q34434911 | Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region |
| Q34746607 | Mutational analysis of varicella-zoster virus major immediate-early protein IE62. |
| Q43203463 | Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase |
| Q33935067 | Regulation of varicella-zoster virus gene expression in human T lymphocytes |
| Q33769312 | Role of the IE62 consensus binding site in transactivation by the varicella-zoster virus IE62 protein |
| Q36724531 | Strong transcriptional activators isolated from viral DNA by the 'activator trap', a novel selection system in mammalian cells |
| Q40404992 | The DNA binding domain of the varicella-zoster virus gene 62 protein interacts with multiple sequences which are similar to the binding site of the related protein of herpes simplex virus type 1. |
| Q40398718 | The DNA binding domains of the varicella-zoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. |
| Q36650274 | The transcriptional activation domain of varicella-zoster virus open reading frame 62 protein is not conserved with its herpes simplex virus homolog |
| Q35841513 | The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. |
| Q35785127 | The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo |
| Q40623905 | Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication |
| Q36634039 | Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. |
| Q24656106 | Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA |
| Q35859868 | Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA |
| Q35839306 | Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency |
| Q36630616 | Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. |